-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OBzK1tLpjUPHuYhMgDHqqeuZ1/BwijJnI7HRuCdeJ9zjDWPIaaGalPstEHeNlJwr uRW7RFnYc6yUo2oaZK9lmA== 0001193125-10-136299.txt : 20100610 0001193125-10-136299.hdr.sgml : 20100610 20100609210604 ACCESSION NUMBER: 0001193125-10-136299 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100604 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100610 DATE AS OF CHANGE: 20100609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVENTIV HEALTH INC CENTRAL INDEX KEY: 0001089473 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 522181734 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30318 FILM NUMBER: 10888867 BUSINESS ADDRESS: STREET 1: 200 COTTONTAIL LANE STREET 2: VANTAGE COURT NORTH CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: 732-537-4800 MAIL ADDRESS: STREET 1: 200 COTTONTAIL LANE STREET 2: VANTAGE COURT NORTH CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: VENTIV HEALTH INC DATE OF NAME CHANGE: 19990810 FORMER COMPANY: FORMER CONFORMED NAME: SNYDER HEALTHCARE SERVICES INC DATE OF NAME CHANGE: 19990624 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) June 4, 2010

 

 

inVentiv Health, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

DELAWARE

(State or Other Jurisdiction of Incorporation)

 

0-30318   52-2181734
(Commission File Number)   (IRS Employer Identification No.)

 

500 ATRIUM DRIVE, SOMERSET, NEW JERSEY   08873
(Address of Principal Executive Offices)   (Zip Code)

(800) 416-0555

(Registrant’s Telephone Number, Including Area Code)

(Not Applicable)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 4, 2010, the Compensation Committee of the Board of Directors of inVentiv Health, Inc. (the “Company”) approved a bonus award to Nat Krishnamurti, the Company’s Chief Accounting Officer, of $235,000 payable 50% on October 1, 2010 and 50% on April 1, 2011, subject to his continued employment by the Company on such dates. Any unpaid portion of this bonus will be accelerated and paid if Mr. Krishnamurti is terminated without cause prior to the applicable payment date.

Item 5.03. Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year

Effective June 8, 2010, the Board of Directors amended Article I, Section 6 (“Quorum”) of the Company’s bylaws, as previously amended and restated, to conform the voting standard for certain matters set forth in such section of the bylaws to the voting standard for such matters set forth in Article I, Section 8 (“Voting; Proxies; Required Vote”). The Company has historically regarded the voting standard in Article I, Section 8 as the operative voting standard.

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 8, 2010, the Company held its 2010 Annual Meeting of Stockholders. Below is a summary of the proposals and corresponding votes.

All seven nominees were elected with each director receiving the following votes:

 

Nominee

   For    Withheld

Eran Broshy

   26,018,629    1,205,973

R. Blane Walter

   26,264,103    960,499

Terrell G. Herring

   24,163,619    3,060,983

Mark E. Jennings

   26,748,032    476,570

Per G.H. Lofberg

   26,747,650    476,952

A. Clayton Perfall

   26,390,460    834,142

Craig Saxton, M.D.

   26,091,537    1,133,065

There were 4,112,854 broker non-votes on this proposal.

The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2010 received the following votes:

 

For

  

Against

            

Abstain

30,914,675

   411,614          11,167

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit 3.2 Amendment to Amended and Restated Bylaws

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    INVENTIV HEALTH, INC.
Date: June 9, 2010     By   /s/ David Bassin
        Name: David Bassin
        Title: Chief Financial Officer and Secretary

 

3


Exhibit Index

 

Exhibit No.

  

Description

Exhibit 3.2    Amendment to Amended and Restated Bylaws

 

4

EX-3.2 2 dex32.htm AMENDMENT TO AMENDED AND RESTATED BYLAWS Amendment to Amended and Restated Bylaws

Exhibit 3.2

RESOLVED, that the second sentence of Article I, Section 6 of the Amended and Restated Bylaws of the Company is hereby amended in its entirety to read as follows:

At all meetings of the stockholders at which a quorum is present, all matters, except as otherwise provided by law or the Certificate of Incorporation, shall be decided by a majority of the votes cast thereat in person or by proxy.

-----END PRIVACY-ENHANCED MESSAGE-----